Medical and surgical management of nasal polyps

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 9, Issue 1, 2001, Pages 27-36

  Assanasen, Paraya ^a   Naclerio, Robert M ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BUDESONIDE; CORTICOSTEROID; FLUOCORTOLONE; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; ROXITHROMYCIN;

APOPTOSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NOSE POLYP; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; REVIEW; STEROID THERAPY;

EID: 0035134512     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200102000-00007     Document Type: Review

References (87)

1. Epidemiology of nasal polyps
2. Rhinoscopy: Endoscopic diagnosis
3. Quality of life in nasal polyposis
4. Nasal polyps in asthma and rhinitis: A review of 6,037 patients
5. Prevalence of asthma, aspirin intolerance, nasal polyposis, and chronic obstructive pulmonary disease in a population-based study
6. Eosinophilic airway inflammation in nasal polyposis
7. The prevalence of nasal polyps in adults with cystic fibrosis
8. Hypersensitivity to molds in patients with nasal polyposis: A clinical study
9. Nasal polyposis: Role of subclinical delayed food hypersensitivity
10. The relationship of nasal polyps, infection, and inflammation
11. Distribution of RANTES and interleukin-5 in allergic nasal mucosa and nasal polyps
12. Nasal polyposis: Eosinophils and interleukin-5
13. Interaction between fibronectin and eosinophils in the growth of nasal polyps
14. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor
15. Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps
16. Overexpression of Fas-ligand in human nasal polyps
17. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis
18. Arachidonic acid metabolisrn in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics
19. Aspirin intolerance in patients with chronic sinusitis
20. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
21. Levels of intracellular protein and messenger RNA of mucin and lysozyme in normal human nasal and polyp epithelium
22. Inflammatory cells in nasal mucosa and nasal polyps
23. Eotaxin synthesis by nasal polyp fibroblasts
24. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts
25. Cytokines and inflammatory cells
26. Adhesion molecules and recruitment of eosinophils
27. Loss of nocturnal decline of blood pressure in patients with nasal polyposis
28. Role of middle meatus aspiration culture in the diagnosis of chronic sinusitis
29. Relative value of MR imaging as compared with CT in the diagnosis of inflammatory paranasal sinus disease
30. Staging for rhinosinusitis
31. Imaging and staging
32. Effect of corticosteroids on nasal polyps: Evidence from controlled trials
33. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts
34. Nasal polyp inflammation: Effect of topical nasal steroid
35. Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient
36. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps
37. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease
38. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia
39. Effect of prednisolone on cytokine synthesis in nasal polyps
40. Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies
41. Expression of GRβ in nasal polyps and its relationship to glucocorticoid responsiveness
42. Guidelines for the management of nasal polyposis
43. Videoendoscopic analysis of nasal steroid distribution
44. Pharmaceutical properties of fluticasone propionate nasal drops: A new formulation
45. Systemic bioavailability of fluticasone propionate administered as nasal drops (FP-drops) and aqueous nasal spray formulations (FPANS)
46. The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis
47. Allergic fungal sinusitis: The role of immunotherapy
48. Aspirin-induced asthma: Advances in pathogenesis and management
49. Computer-aided endoscopic sinus surgery
50. Soft-tissue shavers in pediatric sinus surgery
51. The "hummer": New instrumentation for functional endoscopic sinus surgery
52. Histopathology of tissue samples removed using the microdebrider technique: Implications for endoscopic sinus surgery
53. Initial report on postoperative healing after endoscopic sinus surgery with the microdebrider
54. Objective and subjective outcomes in surgery for chronic sinusitis
55. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis
56. Effect of fluticasone in severe polyposis
57. Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation
58. Efficacy of topical corticosteroid powder for nasal polyps: A double-blind, placebo-controlled study of budesonide
59. Management of nasal polyps by steroid nose drops
60. Endoscopically guided frontal sinus beclomethasone instillation for refractory frontal sinus/recess mucosal edema and polyposis
61. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily and twice daily in the treatment of bilateral nasal polyposis: A placebo-controlled randomized study in adult patients
62. Results of oral steroid treatment in nasal polyposis
63. Glucocorticoid treatment for nasal polyps: A study of budesonide powder and depot-steroid injection
64. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging
65. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis
66. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease
67. Prognostic factors, outcomes, and staging in ethmoid sinus surgery
68. One-year outcome analysis of functional endoscopic sinus surgery for chronic sinusitis
69. Follow-up results of 415 patients after endoscopic sinus surgery
70. Meta-analysis of outcomes of pediatric functional endoscopic sinus surgery
71. Long-term results of functional endoscopic sinus surgery
72. The outcome of endoscopic sinus surgery: Correlation with computerized tomography score and systemic disease
73. Simple clinical system for the prediction of recurrence of nasal polyps
74. Clinical outcomes in patients with chronic sinusitis
75. Objective and subjective assessment of nasal obstruction in patients undergoing endoscopic sinus surgery
76. A prospective study of olfaction following endoscopic sinus surgery with adjuvant medical treatment
77. Ciliary beat frequency, olfaction and endoscopic sinus surgery
78. Endonasal sinus surgery improves mucociliary transport in severe chronic sinusitis
79. Pre- and postoperative mucociliary clearance in functional endoscopic sinus surgery
80. The effect of endoscopic sinus surgery on mucociliary clearance in patients with chronic sinusitis
81. Olfactory function after functional endoscopic sinus surgery for chronic sinusitis
82. Clinical value of olfactory function tests after endoscopic sinus surgery: A short-term result
83. Long-term impact of functional endoscopic sinus surgery on asthma
84. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis
85. The effect of endoscopic sinus surgery on asthma: Management of patients with chronic rhinosinusitis, nasal polyposis, and asthma
86. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad
87. Effects of sinus surgery on asthma in aspirin triad patients